Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons

Neurology

Volumn 61, Issue 8, 2003, Pages 1102-1107

  Wilson, Robert S ^a,b   Schneider, J A ^a,b   Bienias, J L ^a,b   Arnold, S E ^c   Evans, D A ^a,b   Bennett, D A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN;

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; ATYPICAL DEPRESSION; AUTOPSY; BRAIN DEATH; BRAIN REGION; BRAIN SLICE; CLERGY; CLINICAL EXAMINATION; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RATING SCALE; SENESCENCE; SENILE PLAQUE; SEX DIFFERENCE;

EID: 0345047711     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000092914.04345.97     Document Type: Article

References (41)

1. Burt DB, Zembar MJ, Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 1995;117:285-305.
2. Rabbitt P, Donlan C, Watson P, McInnes L, Bent N. Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. Psychol Aging 1995;10:307-313.
3. Teri L, Wagner A. Alzheimer's disease and depression. J Consult Clin Psychol 1992;60:379-391.
4. Bassuk SS, Berkman LF, Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 1998;55:1073-1081.
5. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-370.
6. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS. Depressive symptoms and cognitive decline in nondemented elderly women. Arch Gen Psychiatry 1999;56:425-430.
7. Berger A-K, Fratiglioni L, Forsell Y, Winblad B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
8. Devanand DP, Sano M, Tang M-X, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-182.
9. Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999;56:261-266.
10. Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA 2002;287:742-748.
11. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17: 179-193.
12. Bennett DA, Wilson RS, Schneider JA, et al. The natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
14. Welsh KA, Butters NC, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: a normative study of the neuropsychological battery. Neurology 1994;44:609-614.
15. Albert MS, Smith L, Scherr P, Taylor J, Evans DA, Funkenstein H. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
16. Weschler D. Wechsler Memory Scale-Revised manual. San Antonio, TX: Psychological Corp., 1987.
17. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger, 1983.
18. Nelson HE. National Adult Reading Test (NART) manual. Windsor, UK: NFER-NELSON Publishing, 1982.
19. Ekstrom RB, French JW, Harman HH, Kermen D. Manual for kit of factor-referenced cognitive tests. Princeton, NJ: Educational Testing Service, 1976.
20. Cooper JA, Sager HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
21. Craik FIM. A functional account of age differences in memory. In: Klix E, Hagendorf H, eds. Human memory and cognitive capabilities: mechanisms and performances. Amsterdam: Elsevier Science Publishers BV, 1986;409-422.
22. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological Services, 1982.
23. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1992.
24. Raven JC, Court JH, Raven J. Manual for Raven's progressive matrices and vocabulary scales. Oxford, UK: Oxford University Press, 1992.
25. Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999;159:1701-1704.
26. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993; 5:179-193.
27. Radloff LS. The CES-D scale: a self report depression scale for research in the General population. Appl Psychol Meas 1977;1:385-401.
28. Shrout PE, Yager TJ. Reliability and validity of screening scales: effect of reducing scale length. J Clin Epidemiol 1989;42:69-78.
29. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.
30. Kordower JH, Chu Y, Stebbins GT, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001;49:202-213.
31. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-252.
32. SAS Institute Inc. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, 2000.
33. Hartlage S, Alloy LB, Vazquez C, Dykman B. Automatic and effortful processing in depression. Psychol Bull 1993;113:247-278.
34. Perlmutter M, Nyquist L. Relationships between self-reported physical and mental health and intelligence performance across adulthood. J Gerontol 1990;45:P145-P155.
35. Kase CS, Wolf PA, Kelly-Hayes M, Kannel WB, Beiser A, D'Agostino RB. Intellectual decline after stroke: the Framingham Study. Stroke 1998;29:805-812.
36. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000;57:1071-1076.
37. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depressive symptoms in the cardiovascular health study. Stroke 1999;30:2159-2166.
38. Zubenko GS, Moossy J. Major depression in primary dementia: clinical and neuropathologic correlates. Arch Neurol 1988;45:1182-1186.
39. Forstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R. Clinical and neuropathologic correlates of depression in Alzheimer's disease. Psychol Med 1992;22:877-884.
40. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990;47:209-214.
41. Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci USA 2001;98:12320-12322.